SCHEMBL8300663

SCHEMBL8300663

CC(C)(C)OC(=O)N1C(=O)C[C@H](Cc2ccccc2)[C@H]1CCC(C)(C)[Si](C)(C)O

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KLK7 P49862 8/20 0.43
KLK5 Q9Y337 7/20 0.41
PRSS1 P07477 3/20 0.39
PRSS2 P07478 3/20 0.39
PRSS3 P35030 3/20 0.39
PLA2G10 O15496 1/20 0.37
PLA2G5 P39877 1/20 0.37
STS P08842 1/20 0.37
PARP1 P09874 1/20 0.36
GAA P10253 1/20 0.36
THRB P10828 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
P2RX7 Q99572 2/20 0.35
NR1H2 P55055 2/20 0.34
NR1H3 Q13133 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10025391 0.82 KLK7 (0.44) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL353104 0.82 KLK7 (0.44) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL12644308 0.78 KLK7 (0.36) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL10386719 0.76 KLK7 (0.51) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL7334611 0.76 KLK7 (0.51) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL10387738 0.76 KLK7 (0.51) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL247530 0.74 KLK7 (0.54) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL8300605 0.72 ATM (0.34) PARP1THRBSMN1; SMN2
SCHEMBL12067898 0.72 KLK7 (0.36) KLK7KLK5PRSS1PRSS2PRSS3
SCHEMBL15383781 0.71 KLK7 (0.51) KLK7KLK5PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1636208-B1 INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE VERTEX PHARMA (US) 2012-02-29 EP disclosed
WO-2004092162-A1 INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE VERTEX PHARMACEUTICALS, INCORPORATED (US) 2004-10-28 WO disclosed